by McDermott + Bull | May 19, 2026 | Article, Ken Dropiewski, Ken Dropiewski Article
The best candidates aren’t waiting for you. That’s the part most hiring teams miss. When a high-performing executive decides to explore their next opportunity, they don’t explore just yours. They explore the market — and the company that moves with...
by McDermott + Bull | Mar 20, 2026 | Article, Ken Dropiewski, Ken Dropiewski Article
Scaling a team isn’t about hiring faster or adding headcount. It’s about scaling clarity at the same pace as growth. Most companies don’t struggle because they can’t attract talent. They struggle because roles, expectations, and decision rights blur as the...
by McDermott + Bull | Feb 19, 2026 | Ken Dropiewski, Investor Insights, Video
McDermott + Bull Partner Ken Dropiewski sits down with Terri Burke of Intuitive Ventures to discuss her journey from MedTech operator to investor, Intuitive’s broad approach to shaping the future of healthcare, and what founders should know about raising capital in...
by McDermott + Bull | Dec 1, 2025 | Placement Announcement, Brittany Stansfield, Brittany Stansfield Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jennifer Ness, Ken Dropiewski, Ken Dropiewski Placement Announcement, Paul Gibbons, Paul Gibbons Placement Announcement
McDermott + Bull has successfully placed Lisa Downey as Chief Executive Officer at DrugBank. In this role, Lisa will lead the company’s next phase of growth, deepening its impact across pharmaceutical R&D and AI-driven drug discovery while scaling commercial...
by McDermott + Bull | Nov 4, 2025 | Ken Dropiewski, Article, Ken Dropiewski Article
In today’s employment landscape, innovation alone isn’t enough to win the race for top talent. The most capable executives and emerging leaders aren’t just looking for another job — they’re searching for a mission worth committing to. They want to see substance behind...
by McDermott + Bull | Oct 29, 2025 | Ken Dropiewski, Investor Insights, Video
McDermott + Bull Partner Ken Dropiewski sits down with Kate Garrett of Sonder Capital to explore her journey, the firm’s investment philosophy, and the current MedTech landscape. Kate shares how Sonder identifies bold technologies that can redefine patient care, why...
